Understanding how certain proteins help bacteria survive in the human body.
Nitrosative stress and NO detoxifying reaction mechanisms in microbial nonheme diiron proteins
This study is looking at how certain proteins in harmful bacteria help them survive when our immune system tries to fight them off, which could lead to new ways to tackle infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11030269 on NIH RePORTER |
What this research studies
This research investigates the role of metalloenzymes, specifically nonheme diiron proteins, in helping pathogenic bacteria survive the human immune response. By using advanced biochemical techniques and spectroscopies, the study aims to uncover how these proteins detoxify reactive nitrogen species, which are harmful to both bacteria and human cells. The research focuses on a unique mycobacterial protein that shows unusual structural features and reactivity, potentially revealing new insights into bacterial survival mechanisms during infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with infections caused by mycobacterial pathogens, such as those with disseminated tuberculosis.
Not a fit: Patients with non-infectious conditions or those not affected by mycobacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating bacterial infections by targeting their detoxification mechanisms.
How similar studies have performed: While the specific approach of investigating this novel mycobacterial protein is relatively new, similar studies on metalloenzymes have shown promise in understanding bacterial resistance mechanisms.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Moenne-Loccoz, Pierre — Oregon Health & Science University
- Study coordinator: Moenne-Loccoz, Pierre
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.